{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:46:45Z","timestamp":1773298005771,"version":"3.50.1"},"reference-count":95,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["NSERC-03629"],"award-info":[{"award-number":["NSERC-03629"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["CIHR-PJT-156394"],"award-info":[{"award-number":["CIHR-PJT-156394"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.neuropharm.2018.08.039","type":"journal-article","created":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T07:32:46Z","timestamp":1536305566000},"page":"272-282","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Conditioned gaping produced by high dose \u03949-tetrahydracannabinol: Dysregulation of the hypothalamic endocannabinoid system"],"prefix":"10.1016","volume":"141","author":[{"given":"Marieka V.","family":"DeVuono","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly M.","family":"Hrelja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren","family":"Sabaziotis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Rajna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin M.","family":"Rock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheryl L.","family":"Limebeer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Mutch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda A.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2018.08.039_bib1","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1136\/gut.2003.036350","article-title":"Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse","volume":"53","author":"Allen","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.neuropharm.2018.08.039_bib2","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.autneu.2006.01.008","article-title":"Signals for nausea and emesis: implications for models of upper gastrointestinal diseases","volume":"125","author":"Andrews","year":"2006","journal-title":"Auton. Neurosci. Basic Clin"},{"key":"10.1016\/j.neuropharm.2018.08.039_bib3","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/0006-8993(92)90432-9","article-title":"Area postrema mediation of physiological and behavioral effects of lithium chloride in the rat","volume":"575","author":"Bernstein","year":"1992","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2018.08.039_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14782","article-title":"Endocannabinoid signalling modulates susceptibility to traumatic stress exposure","author":"Bluett","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2018.08.039_bib6","article-title":"Chronic \u232c 9 -tetrahydrocannabinol treatment produces a time- dependent loss of cannabinoid receptors and cannabinoid receptor-activated G proteins in rat brain","volume":"2","author":"Breivogel","year":"1999","journal-title":"Reactions"},{"key":"10.1016\/j.neuropharm.2018.08.039_bib7","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0014-2999(02)02854-6","article-title":"The effects of \u03949-tetrahydrocannabinol physical dependence on brain cannabinoid receptors","volume":"459","author":"Breivogel","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.08.039_bib9","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3357\/ASEM.2903.2011","article-title":"Various anti-motion sickness drugs and core body temperature changes","volume":"82","author":"Cheung","year":"2011","journal-title":"Aviat Space Environ. Med."},{"key":"10.1016\/j.neuropharm.2018.08.039_bib10","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1742-7843.2008.00253.x","article-title":"The effects of cannabidiol and tetrahydrocannabinol on motion-induced emesis in Suncus murinus","volume":"103","author":"Cluny","year":"2008","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"80","key":"10.1016\/j.neuropharm.2018.08.039_bib11","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1126\/science.1145590","article-title":"Inactivation of the interoceptive insula disrupts drug craving and malaise induced by lithium","volume":"318","author":"Contreras","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2018.08.039_bib12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/384083a0","article-title":"Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides","volume":"384","author":"Cravatt","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2018.08.039_bib13","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1037\/0735-7044.107.3.468","article-title":"Drug-induced hypothermia and conditioned place aversion","volume":"107","author":"Cunningham","year":"1993","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.08.039_bib14","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.3390\/ph3072163","article-title":"Cannabinoid-induced hyperemesis: a conundrum-from linical recognition to basic science mechanisms","volume":"3","author":"Darmani","year":"2010","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.neuropharm.2018.08.039_bib15","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1124\/jpet.300.1.34","article-title":"The potent emetogenic effects of the endocannabinoid, 2-AG (2-arachidonoylglycerol) are blocked by delta 9-tetrahydrocannabinol and other cannnabinoids","volume":"300","author":"Darmani","year":"2002","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2018.08.039_bib16","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0091-3057(01)00531-7","article-title":"Delta-9-tetrahydrocannabinol differentially suppresses cisplatin-induced emesis and indices of motor function via cannabinoid CB1 receptors in the least shrew","volume":"69","author":"Darmani","year":"2001","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2018.08.039_bib17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0014-2999(01)01355-3","article-title":"The cannabinoid CB1 receptor antagonist SR 141716A reverses the antiemetic and motor depressant actions of WIN 55, 212-2","volume":"430","author":"Darmani","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.08.039_bib19","doi-asserted-by":"crossref","DOI":"10.1007\/s00213-017-4714-6","article-title":"Effect of footshock stress on place conditioning produced by delta9-tetrahydrocannabinol and the fatty acid amide hydrolase (faah) inhibitor, urb597, in sprague-dawley rats","author":"DeVuono","year":"2017","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neuropharm.2018.08.039_bib20","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1124\/mol.104.002071","article-title":"RNA interference suggests a primary role for monoacylglycerol lipase in the degradation of the endocannabinoid 2-arachidonoylglycerol","volume":"66","author":"Dinh","year":"2004","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.08.039_bib21","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1037\/0735-7044.110.1.202","article-title":"Area postrema mediates the formation of rapid, conditioned palatability shifts in lithium-treated rats","volume":"110","author":"Eckel","year":"1996","journal-title":"Behav. Neurosci."},{"issue":"80","key":"10.1016\/j.neuropharm.2018.08.039_bib22","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1126\/science.175.4024.911","article-title":"Delta9 -Tetrahydrocannabinol\u202f: aversive effects in rat at high doses","volume":"175","author":"Elsmore","year":"1972","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2018.08.039_bib23","first-page":"399","article-title":"Changes in the afferent abdominal vagal nerve activity induced by cisplatin and copper sulfate in the ferret","volume":"11","author":"Endo","year":"1995","journal-title":"Biog. Amines"},{"key":"10.1016\/j.neuropharm.2018.08.039_bib24","doi-asserted-by":"crossref","first-page":"4811","DOI":"10.1210\/en.2010-0285","article-title":"Fast feedback inhibition of the HPA axis by glucocorticoids is mediated by endocannabinoid signaling","volume":"151","author":"Evanson","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuropharm.2018.08.039_bib25","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1007\/s00213-015-3970-6","article-title":"Effect of norbinaltorphimine on \u03949-tetrahydrocannabinol (THC)-induced taste avoidance in adolescent and adult Sprague-Dawley rats","volume":"232","author":"Flax","year":"2015","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neuropharm.2018.08.039_bib26","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1177\/0960327111421945","article-title":"Synthetic cannabinoid and marijuana exposures reported to poison centers","volume":"31","author":"Forrester","year":"2012","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.neuropharm.2018.08.039_bib27","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/0003-4819-91-6-825","article-title":"Delta-9-Tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy","volume":"19","author":"Frytak","year":"1979","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.neuropharm.2018.08.039_bib28","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0006-8993(78)90568-1","article-title":"The taste reactivity test. I. Mimetic responses to gustatory stimuli in neurologically normal rats","volume":"143","author":"Grill","year":"1978","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2018.08.039_bib29","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1038\/npp.2009.114","article-title":"Suppression of amygdalar endocannabinoid signaling by stress contributes to activation of the hypothalamic-pituitary- adrenal Axis","volume":"34","author":"Hill","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.08.039_bib30","doi-asserted-by":"crossref","first-page":"14980","DOI":"10.1523\/JNEUROSCI.4283-10.2010","article-title":"Functional interactions between stress and the endocannabinoid system: from synaptic signaling to behavioral output","volume":"30","author":"Hill","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.08.039_bib31","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.neuroscience.2011.12.030","article-title":"Endocannabinoid signaling, glucocorticoid-mediated negative feedback, and regulation of the hypothalamic-pituitary-adrenal axis","volume":"204","author":"Hill","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2018.08.039_bib32","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/mp.2011.82","article-title":"Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers","volume":"17","author":"Hirvonen","year":"2012","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.08.039_bib33","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.autneu.2004.08.011","article-title":"Differential effects on gastrointestinal and hepatic vagal afferent fibers in the rat by the anti-cancer agent cisplatin","volume":"115","author":"Horn","year":"2004","journal-title":"Auton. Neurosci. Basic Clin"},{"key":"10.1016\/j.neuropharm.2018.08.039_bib34","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0002-9343(01)00849-X","article-title":"Central neurocircuitry associated with emesis","volume":"111","author":"Hornby","year":"2001","journal-title":"Am. J. Med."},{"key":"10.1016\/j.neuropharm.2018.08.039_bib35","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1111\/j.1462-5822.2007.00957.x","article-title":"Staphylococcal enterotoxin induces emesis through increasing serotonin release in intestine and it is downregulated by cannabinoid receptor 1","volume":"9","author":"Hu","year":"2007","journal-title":"Cell Microbiol."},{"key":"10.1016\/j.neuropharm.2018.08.039_bib36","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1517\/14728210902736568","article-title":"Cannabinoid receptor antagonists: pharmacological opportunities, clinical experience, and translational prognosis","volume":"14","author":"Janero","year":"2009","journal-title":"Expet Opin. Emerg. Drugs"},{"key":"10.1016\/j.neuropharm.2018.08.039_bib37","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1037\/0735-7044.106.1.140","article-title":"Taste avoidance, but not aversion, learning in rats lacking gustatory cortex","volume":"106","author":"Kiefer","year":"1992","journal-title":"Behav. Neuroscience"},{"key":"10.1016\/j.neuropharm.2018.08.039_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000412","article-title":"Imporving bioscience research reporting: the ARRIVE guidelines for reporting animal research","volume":"8","author":"Kilkenny","year":"2010","journal-title":"PLoS Biol."},{"key":"10.1016\/j.neuropharm.2018.08.039_bib39","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0014-2999(00)00615-4","article-title":"SR 141716A enhances spatial memory as assessed in a radial-arm maze task in rats","volume":"404","author":"Lichtman","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.08.039_bib40","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s00213-002-1309-6","article-title":"The 5-HT1A agonist 8-OH-DPAT dose-dependently interferes with the establishment and the expression of lithium-induced conditioned rejection reactions in rats","volume":"166","author":"Limebeer","year":"2003","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neuropharm.2018.08.039_bib41","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1037\/0097-7403.26.4.371","article-title":"The antiemetic drug ondansetron interferes with lithium-induced conditioned rejection reactions, but not lithium-induced taste avoidance in rats","volume":"26","author":"Limebeer","year":"2000","journal-title":"J. Exp. Psychol. Anim. Behav. Process."},{"key":"10.1016\/j.neuropharm.2018.08.039_bib42","doi-asserted-by":"crossref","first-page":"3769","DOI":"10.1097\/00001756-199912160-00009","article-title":"Delta-9-tetrahydrocannabinol interferes with the establishment and the expression of conditioned rejection reactions produced by cyclophosphamide: a rat model of nausea","volume":"10","author":"Limebeer","year":"1999","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2018.08.039_bib43","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1111\/j.1476-5381.2012.02066.x","article-title":"The anti-nausea effects of CB1 agonists are mediated by an action at the visceral insular cortex","volume":"167","author":"Limebeer","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.08.039_bib44","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1476-5381.2010.00885.x","article-title":"Inverse agonism of cannabinoid CB 1 receptors potentiates LiCl-induced nausea in the conditioned gaping model in rats","volume":"161","author":"Limebeer","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.08.039_bib46","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.tips.2004.04.005","article-title":"Signaling pathways involved in the development of cannabinoid tolerance","volume":"25","author":"Martin","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2018.08.039_bib47","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejphar.2009.09.055","article-title":"Monoaminergic neurotransmission contributes to cannabinoid-induced activation of the hypothalamic-pituitary-adrenal axis","volume":"624","author":"McLaughlin","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.08.039_bib48","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s00213-005-2171-0","article-title":"The cannabinoid CB1 antagonist AM 251 produces food avoidance and behaviors associated with nausea but does not impair feeding efficiency in rats","volume":"180","author":"McLaughlin","year":"2005","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neuropharm.2018.08.039_bib49","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1021\/ja01092a065","article-title":"A total synthesis of Dl-delta-1-tetrahydrocannabinol, the active constituent of hashish","volume":"87","author":"Mechoulam","year":"1965","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.neuropharm.2018.08.039_bib50","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1469-7793.2001.00619.x","article-title":"Motion sickness potentiates core cooling during immersion in humans","volume":"535","author":"Mekjavic","year":"2001","journal-title":"J. Physiol"},{"key":"10.1016\/j.neuropharm.2018.08.039_bib52","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1006\/nbdi.1998.0224","article-title":"Function of cannabinoid receptors in the neuroendocrine regulation of hormone secretion","volume":"5","author":"Murphy","year":"1998","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2018.08.039_bib53","first-page":"1207","article-title":"Central circuitries for body temperature regulation and fever","volume":"305","author":"Nakamura","year":"2011","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.neuropharm.2018.08.039_bib54","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/cercor\/bhs073","article-title":"The brain circuitry underlying the temporal evolution of nausea in humans","volume":"23","author":"Napadow","year":"2013","journal-title":"Cerebr. Cortex"},{"key":"10.1016\/j.neuropharm.2018.08.039_bib55","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.18632\/oncotarget.1732","article-title":"Thermoregulatory correlates of nausea in rats and musk shrews","volume":"5","author":"Ngampramuan","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.neuropharm.2018.08.039_bib56","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1007\/s00421-011-2142-6","article-title":"EVects of motion sickness on thermoregulatory responses in a thermoneutral air environment","volume":"112","author":"Nobel","year":"2012","journal-title":"Eur. J. Appl. Physiol."},{"key":"10.1016\/j.neuropharm.2018.08.039_bib57","doi-asserted-by":"crossref","DOI":"10.1002\/j.1552-4604.1975.tb02348.x","article-title":"The analgesic properties of delta-9-tetrahydrocannabinol and codeine","author":"Noyes","year":"1975","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.08.039_bib58","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0022-3565(25)13195-9","article-title":"Pharmacological characterization of cannabinoids in the elevated plus maze","volume":"253","author":"Onaivi","year":"1990","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2018.08.039_bib59","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ejphar.2013.09.070","article-title":"Conditioned flavor avoidance and conditioned gaping: rat models of conditioned nausea","volume":"722","author":"Parker","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.08.039_bib60","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3758\/BF03195979","article-title":"Taste avoidance and taste aversion: evidence for two different processes","volume":"31","author":"Parker","year":"2003","journal-title":"Anim. Learn. Behav."},{"key":"10.1016\/j.neuropharm.2018.08.039_bib61","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0149-7634(94)00028-Y","article-title":"Rewarding drugs produce taste avoidance, but not taste aversion","volume":"19","author":"Parker","year":"1995","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2018.08.039_bib62","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1037\/0735-7044.109.1.71","article-title":"THC-induced place and taste aversions in lewis and sprague-dawley rats","volume":"109","author":"Parker","year":"1995","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.08.039_bib63","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s00213-003-1571-2","article-title":"Effect of cannabinoids on lithium-induced vomiting in the Suncus murinus (house musk shrew)","volume":"171","author":"Parker","year":"2004","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neuropharm.2018.08.039_bib64","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s00213-002-1329-2","article-title":"Effects of cannabinoids on lithium-induced conditioned rejection reactions in a rat model of nausea","volume":"166","author":"Parker","year":"2003","journal-title":"Psychopharmacol"},{"key":"10.1016\/j.neuropharm.2018.08.039_bib66","doi-asserted-by":"crossref","first-page":"5431","DOI":"10.1210\/en.2004-0638","article-title":"Endocannabinoid signaling negatively modulates stress- induced activation of the hypothalamic-pituitary- adrenal axis","volume":"145","author":"Patel","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuropharm.2018.08.039_bib67","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1460-9568.2005.03916.x","article-title":"Inhibition of restraint stress-induced neural and behavioural activation by endogenous cannabinoid signalling","volume":"21","author":"Patel","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.08.039_bib68","series-title":"The Rat Brain in Stereotaxic Coordinates in Stereotaxic Coordinates","author":"Paxinos","year":"2007"},{"key":"10.1016\/j.neuropharm.2018.08.039_bib69","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/brain\/78.4.445","article-title":"The insula: further OBservations on its function","volume":"78","author":"Penfield","year":"1955","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2018.08.039_bib70","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1476-5381.2008.00048.x","article-title":"Emerging strategies for exploiting cannabinoid receptor agonists as medicines","volume":"156","author":"Pertwee","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.08.039_bib71","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/jama.295.7.761","article-title":"Effect of rimonabant, a Cannabinoid-1 receptor blocker, on weight and cardiometaboloc risk factors in overweight or obese patients","volume":"295","author":"Pi-sunyer","year":"2006","journal-title":"Jama"},{"key":"10.1016\/j.neuropharm.2018.08.039_bib72","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF00238101","article-title":"Corticotrophin and corticosterone secretion following \u03941-tetrahydrocannabinol, in intact and in hypothalamic deafferentated male rats","volume":"46","author":"Puder","year":"1982","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.neuropharm.2018.08.039_bib1a","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2017.04.018","article-title":"Cannabinoid hyperemesis syndrome: a disorder of the HPA axis and sympathetic nervous system?","author":"Richards","year":"2017","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.neuropharm.2018.08.039_bib73","doi-asserted-by":"crossref","DOI":"10.1002\/phar.1931","article-title":"Pharmacologic treatment of cannabinoid hyperemesis syndrome: a systematic review","author":"Richards","year":"2017","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.neuropharm.2018.08.039_bib74","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1111\/j.1476-5381.2011.01621.x","article-title":"Cannabidiol, a nonpsychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT 1A somatodendritic autoreceptors in the dorsal raphe nucleus","volume":"165","author":"Rock","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.08.039_bib75","first-page":"1","article-title":"Effect of prior foot shock stress and \u03949-tetrahydrocannabinol, cannabidiolic acid, and cannabidiol on anxiety-like responding in the light-dark emergence test in rats","author":"Rock","year":"2017","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neuropharm.2018.08.039_bib76","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1111\/bph.13980","article-title":"Suppression of acute and anticipatory nausea by peripherally restricted fatty acid amide hydrolase inhibitor in animal models: role of PPAR\u03b1 and CB1 receptors","volume":"174","author":"Rock","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.08.039_bib77","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/(SICI)1098-2396(199811)30:3<298::AID-SYN7>3.0.CO;2-6","article-title":"Time-course of the cannabinoid receptor down-regulation in the adult rat brain caused by repeated exposure to delta9-tetrahydrocannabinol","volume":"30","author":"Romero","year":"1998","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2018.08.039_bib78","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0169-328X(96)00277-X","article-title":"Effects of chronic exposure to delta9-tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions","volume":"46","author":"Romero","year":"1997","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.neuropharm.2018.08.039_bib79","first-page":"2493","article-title":"Chronic CP-55,940 alters cannabinoid receptor mRNA in the rat brain: an in situ hybridization study","volume":"5","author":"Rubino","year":"1994","journal-title":"Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.08.039_bib80","first-page":"485","article-title":"Brain circuitry supporting multi-organ autonomic outflow in response to nausea","volume":"26","author":"Sclocco","year":"2016","journal-title":"Cerebr. Cortex"},{"key":"10.1016\/j.neuropharm.2018.08.039_bib81","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.pnpbp.2012.04.017","article-title":"Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids","volume":"39","author":"Seely","year":"2012","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.08.039_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2013.09.068","article-title":"Regulation of nausea and vomiting by cannabinoids and the endocannabnoid system","volume":"722","author":"Sharkey","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.08.039_bib83","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/sj.npp.1301476","article-title":"The novel cannabinoid CB1 receptor neutral antagonist AM4113 suppresses food intake and food-reinforced behavior but does not induce signs of nausea in rats","volume":"33","author":"Sink","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.08.039_bib84","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s13181-016-0595-z","article-title":"Cannabinoid hyperemesis syndrome: diagnosis, pathophysiology, and treatment\u2014a systematic review","volume":"13","author":"Sorensen","year":"2017","journal-title":"J. Med. Toxicol."},{"key":"10.1016\/j.neuropharm.2018.08.039_bib85","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.neuropharm.2015.10.039","article-title":"Endocannabinoid regulation of nausea is mediated by 2-arachidonoylglycerol (2-AG) in the rat visceral insular cortex","volume":"102","author":"Sticht","year":"2016","journal-title":"Neuropharmachology"},{"key":"10.1016\/j.neuropharm.2018.08.039_bib86","article-title":"Cyclic vomiting syndrome: the corticotropin-releasing-factor hypothesis","volume":"44","author":"Tach\u00e9","year":"1999","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.neuropharm.2018.08.039_bib87","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1172\/JCI30085","article-title":"Corticotropin-releasing factor receptors and stress-related alterations of gut motor function","volume":"117","author":"Tach\u00e9","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neuropharm.2018.08.039_bib88","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1111\/bph.13024","article-title":"Cannabidiol fails to reverse hypothermia or locomotor suppression induced by delta9-tetrahydrocannabinol in Sprague-Dawley rats","volume":"172","author":"Taffe","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.08.039_bib89","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0014-2999(77)90244-8","article-title":"Biphasic nature of the effects of delta9-tetrahydrocannabinol on body temperature and brain amines of the rat","volume":"46","author":"Taylor","year":"1977","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.08.039_bib90","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF02246352","article-title":"Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist SR 141716_","volume":"126","author":"Terranova","year":"1996","journal-title":"Psychopharmachology"},{"key":"10.1016\/j.neuropharm.2018.08.039_bib91","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1037\/0735-7044.100.4.544","article-title":"Electromyographic analysis of the ingestion and rejection of sapid stimuli in the rat","volume":"100","author":"Travers","year":"1986","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.08.039_bib92","doi-asserted-by":"crossref","first-page":"13709","DOI":"10.1523\/JNEUROSCI.2042-12.2012","article-title":"Double dissociation between regulation of conditioned Disgust and taste avoidance by serotonin availability at the 5-HT3 receptor in the posterior and anterior insular cortex","volume":"32","author":"Tuerke","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.08.039_bib93","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/sj.bjp.0704479","article-title":"Behavioural and biochemical evidence for interactions between D 9-tetrahydrocannabinol and nicotine","volume":"135","author":"Valjent","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.08.039_bib94","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1053\/gast.2001.28466","article-title":"Cannabinoids inhibit emesis through CB1 receptors in the brainstem of the ferret","volume":"121","author":"Van Sickle","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.neuropharm.2018.08.039_bib95","doi-asserted-by":"crossref","first-page":"G566","DOI":"10.1152\/ajpgi.00113.2003","article-title":"Delta9-tetrahydrocannabinol selectively acts on CB1 receptors in specific regions of dorsal vagal complex to inhibit emesis in ferrets","volume":"285","author":"Van Sickle","year":"2003","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.neuropharm.2018.08.039_bib96","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3109\/15563658108990042","article-title":"Toxicity with intravenous injection of crude marijuana extract","volume":"18","author":"Vaziri","year":"1981","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.neuropharm.2018.08.039_bib97","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1007\/s00221-014-3967-0","article-title":"An internet survey of marijuana and hot shower use in adults with cyclic vomiting syndrome (CVS)","volume":"232","author":"Venkatesan","year":"2014","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.neuropharm.2018.08.039_bib98","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1007\/s00213-004-2050-0","article-title":"CB1 cannabinoid receptor agonists increase intracranial self-stimulation thresholds in the rat","volume":"179","author":"Vlachou","year":"2005","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neuropharm.2018.08.039_bib99","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.pbb.2013.11.005","article-title":"Conditioned taste avoidance induced by \u03949-tetrahydrocannabinol in the Fischer (F344) and Lewis (LEW) rat strains","volume":"116","author":"Wakeford","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2018.08.039_bib100","first-page":"464","article-title":"Withdrawal phenomena and dependence syndrome after the consumption of \u201cspice gold\u201d","volume":"106","author":"Zimmermann","year":"2009","journal-title":"Dtsch. \u00c4rzteblatt Int."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390818305987?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390818305987?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T23:37:28Z","timestamp":1751845048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390818305987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":95,"alternative-id":["S0028390818305987"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.08.039","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Conditioned gaping produced by high dose \u03949-tetrahydracannabinol: Dysregulation of the hypothalamic endocannabinoid system","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.08.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}